Abterra Biosciences

Abterra Bio is a United States-based biotechnology company headquartered in San Diego, California. The company employs a team of 9 individuals and generates an annual revenue of $2.5 million. Abterra Bio specializes in developing antibody therapeutics. Their technologies leverage next-generation sequencing, mass spectrometry, and machine learning to comprehensively analyze antibody responses. They offer their partners access to a wide range of relevant antibodies to support their specific project requirements. Founded as Digital Proteomics LLC, Abterra Bio emerged from the University of California – San Diego. The company's founders, Pavel Pevzner and Vineet Bafna, are professors in the Computer Science and Engineering Department and renowned bioinformatics researchers. Their academic expertise is the bedrock of Abterra Bio's advanced products and services. For more information about Abterra Bio's services and how they can assist your research, visit their website at abterrabio.com or explore their service guide: abterrabio.com/service-guide/.